What is Jade Biosciences, Inc. Common Stock's market cap?

Jade Biosciences, Inc. Common Stock (JBIO) has a market capitalization of $1.3B and trades on NASDAQ.

Where is Jade Biosciences, Inc. Common Stock headquartered?

Jade Biosciences, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.

Jade Biosciences, Inc. Common Stock

JBIO

Jade Biosciences, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Tom Frohlich, with a market cap of $1.3B.

Market cap

$1.33B+318%

Net income-$129.6M-27.1%

Free cash flow-$94.9M-66.7%

EPS (diluted)-$2.02+93.8%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q1 2026 report

May 7, 2026

EPS-$0.57Miss by $0.05

Read the full report

Next report

Aug 12, 2026 (in 2 months)

EPS estimate-$0.66

Financials

Q1 2026

Income statement

See full

Operating income-$43.4M-85.8%

Net income-$40.4M-5.8%

EPS (diluted)-$0.57+95.3%

Balance sheet

See full

Cash & equivalents$55.1M+24.6%

Total debt$808.0K+159%

Total equity$296.5M+455%

Total assets$319.4M+312%

Cash flow

See full

Operating cash flow-$24.1M-28.4%

CapEx$3.0K—

Free cash flow-$33.7M—

Valuation & ratios

Valuation

See full

Market cap$1.33B—

Enterprise value$1.28B—

Returns & leverage

See full

Return on equity-132.5%+120pp

Debt / equity0×—

Current ratio14.3×-17.7×

Profile

CountryUnited States of America

Listed2025

CEOTom Frohlich

SectorPHARMACEUTICAL PREPARATIONS

IndustryPHARMACEUTICAL PREPARATIONS

Websitejadebiosciences.com

FilingsSEC EDGAR

Questions, answered.

What is Jade Biosciences, Inc. Common Stock's market cap?: Jade Biosciences, Inc. Common Stock (JBIO) has a market capitalization of $1.3B and trades on NASDAQ.
Where is Jade Biosciences, Inc. Common Stock headquartered?: Jade Biosciences, Inc. Common Stock is headquartered in United States of America. It has been publicly traded since 2025.